Clinical trial
Lactate-to-albumin, CRP-to-albumin and Procalcitonin-to-albumin Ratios Predict Mortality in Critically Ill Adults: a Retrospective ICU Cohort Study
NCT07242027 is registered in ClinicalTrials.gov with Medical University of Silesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lactate-to-albumin, CRP-to-albumin and Procalcitonin-to-albumin Ratios Predict Mortality in Critically Ill Adults: a Retrospective ICU Cohort Study
- Lead sponsor
- Medical University of Silesia
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 21, 2025
- Completion date
- September 20, 2025
- Enrollment
- 212 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac arrest, circulatory failure, critical illness, respiratory failure, sepsis, sudden cardiac arrest